Amarantus Bioscience Holdings Inc (AMBS)

[PENNYS ToMILLIONS]

and here is some more $$$

Amarantus BioSciences Receives Grant from Brewer Sports International for Traumatic Brain Injury
SUNNYVALE, CA and MINNEAPOLIS, MN– November 30, 2011 – Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing Mesencephalic-Astrocyte-derived Neurotrophic Factor (MANF), a first-in-class disease–modifying therapeutic protein, today announced a commitment by Brewer Sports International (BSI) to fund a pre-clinical study evaluating MANF’s potential as a treatment for Traumatic Brain Injury (TBI). This funding will support the collaboration recently announced between Amarantus and Banyan Biomarkers.